Impact of drug-eluting stent-associated coronary artery spasm on 3-year clinical outcomes: A propensity score matching analysis

It has been reported that significant endothelial dysfunction or clinically evident vasospasm can be associated with drug-eluting stents (DESs). However, the impact of DES associated coronary artery spasm (CAS) on long-term clinical outcomes has not been fully elucidated as compared with those of pa...

Full description

Saved in:
Bibliographic Details
Published in:Indian heart journal 2022-05, Vol.74 (3), p.182-186
Main Authors: Ali, Jabar, Rha, Seung-Woon, Choi, Byoung Geol, Byun, Jae Kyeong, Choi, Se Yeon, Cha, Jin Ah, Park, Soohyung, Lee, Kyuho, Back, Seungmin, Lee, Jieun, Kang, Dong Oh, Choi, Jah Yeon, Roh, Seung-Young, Na, Jin Oh, Choi, Cheol Ung, Kim, Jin-Won, Kim, Eung Ju, Park, Chang Gyu, Seo, Hong Seog, Wasim, Mohammad, Hassan, Zair
Format: Article
Language:English
Subjects:
Ach: acetylcholine
CAS
Coronary artery spasm
DES
Drug eluting stents
MACE
Major adverse cardiac events
Original
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It has been reported that significant endothelial dysfunction or clinically evident vasospasm can be associated with drug-eluting stents (DESs). However, the impact of DES associated coronary artery spasm (CAS) on long-term clinical outcomes has not been fully elucidated as compared with those of patients with vasospastic angina. A total of 2797 consecutive patients without significant coronary artery lesion (
ISSN:0019-4832
2213-3763
DOI:10.1016/j.ihj.2022.05.002